Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Inhibrx Biosciences (INBX) Assets Average (2024 - 2025)

Inhibrx Biosciences (INBX) has disclosed Assets Average for 1 consecutive years, with $194.8 million as the latest value for Q3 2025.

  • On a quarterly basis, Assets Average changed N/A to $194.8 million in Q3 2025 year-over-year; TTM through Sep 2025 was $194.8 million, a N/A change, with the full-year FY2024 number at $244.3 million, changed N/A from a year prior.
  • Assets Average was $194.8 million for Q3 2025 at Inhibrx Biosciences.
  • In the past five years, Assets Average ranged from a high of $194.8 million in Q3 2025 to a low of $194.8 million in Q3 2025.